AbbVie Inc. (ABBV) Total liabilities 2016–2025
AbbVie Inc. (ABBV) total liabilities at each fiscal year-end, per SEC filings.
$137.2BFY2025 · since FY2016: $61.5B → $137.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $137.2B | +4.1% |
| FY2024 | $131.8B | +6.0% |
| FY2023 | $124.4B | +2.3% |
| FY2022 | $121.6B | -7.3% |
| FY2021 | $131.1B | -4.6% |
| FY2020 | $137.5B | +41.3% |
| FY2019 | $97.3B | +43.5% |
| FY2018 | $67.8B | +3.2% |
| FY2017 | $65.7B | +6.9% |
| FY2016 | $61.5B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice